Abstract
Oropharyngeal candidiasis is caused by Candida sp. , opportunistic yeasts that infect immunocompromised patients. Chemotherapies are based on antifungal drugs against which yeast overexpress and address to the plasma membrane ATP-binding cassette (ABC) pumps for expelling these drugs out of the cell. More critical—because these pumps translocate structurally unrelated drugs—they confer to the yeast a broad resistance to antifungals when expressed, hampering the efficacy of these treatments whatever the drug used. We review here the disease, its treatment, and the role played by multidrug resistance ABC, and strategies to overcome this problem. Keywords: oropharyngeal candidiasis; pathogenic yeasts; fungal drug resistance; drug efflux; ABC transporters; P-glycoprotein; CDR1 (Published: 4 March 2014) Citation: Advances in Cellular and Molecular Otolaryngology 2014, 2 : 23955 - http://dx.doi.org/10.3402/acmo.v2.23955
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
